← Отчётные звонки
CTVA FY2026 Q1 Улучшается

Отчётный звонок Corteva, Inc.

May 06, 2026 · 09:00 ET Chuck MagroDavid JohnsonJudd O'Connor earningscall_biz
Вывод Buzzberg

Corteva reaffirms full-year guidance with strong Q1 EBITDA growth

Corteva delivered a strong Q1 2026, with EBITDA up 21% driven by seed timing and crop protection volume gains. Management maintained full-year guidance, signaling the first half is tracking better than expected, and progressed on its separation plan, naming the new seed company 'Vylor'. Q1 2026 operating EBITDA up 21% to over $1.4 billion, with organic sales up 7%.

Вывод Buzzberg Corteva reaffirms full-year guidance with strong Q1 EBITDA growth Corteva delivered a strong Q1 2026, with EBITDA up 21% driven by seed timing and crop protection volume gains. Management maintained full-year guidance, signaling the first half is tracking better than expected, and progressed on its separation plan, naming the new seed company 'Vylor'. Q1 2026 operating EBITDA up 21% to over $1.4 billion, with organic sales up 7%. Читать полный анализСвернуть анализ

Corteva delivered a strong Q1 2026, with EBITDA up 21% driven by seed timing and crop protection volume gains. Management maintained full-year guidance, signaling the first half is tracking better than expected, and progressed on its separation plan, naming the new seed company 'Vylor'. Q1 2026 operating EBITDA up 21% to over $1.4 billion, with organic sales up 7%.

  • Management reiterated FY2026 guidance of $4.0-4.2B EBITDA and $3.45-3.70 EPS.
  • The company is ahead of schedule on its path to becoming royalty positive in 2026, a fulyear earlier than originally planned.
  • Corteva announced the name 'Vylor' for its future seed and genetics spin-off, with a Q4 separation still on track.
Выручка$4.905B+25% к/к
EPS$1.50Факт
Валовая маржа51.64%Факт
Операционная маржа23.55%Факт
6 подтверждённых тезисов

Что важно сейчас

Самые значимые изменения по итогам звонка.

01
Guidance

Corteva reaffirms full-year guidance with strong Q1 EBITDA growth

02
Margins

First quarter operating EBITDA up 21%, margin expands 240 basis points

03
Seed

Seed business to become royalty positive later this year

Показать ещё 3 тезиса
04
Seed

Enlist soybean technology to cover 65% of U.S. acres

05
Separation

Separation on track for Q4, new companies named

06
Macro

Oil price spike adds $40 million headwind, tariffs favorable

Отчётный период

Фактические результаты

ПоказательФактИзменение
Выручка$4.905B+25% к/к
EPS$1.50Факт
Валовая маржа51.64%Факт
Операционная маржа23.55%Факт
Свободный денежный поток$-2.972BФакт
Капзатраты$0.081BФакт
Прогнозные данные

Прогноз компании

ПоказательПериодДиапазонСерединаСтатус
EPSFY2026$3.45–$3.70В соответствии с консенсусом$3.58Подтверждён
AI, капзатраты и спрос

Оценка менеджмента

Тон

Confident

Management expressed confidence in strong first-quarter results, reaffirmed guidance, and highlighted progress on strategic initiatives like the separation and royalty-positive milestone.

все упомянутые компании ниже: 6

Компаниис момента звонка

Партнёры

Партнёры

Corteva's biofuels program with Bunge and Chevron is progressing well, with good yields and high farmer retention, indicating a strong new revenue stream.

Доказательства
“focused with bungie and Chevron, sustainable aviation fuel. The crop looks good agronomically. Yields look like they're going to be in a favorable position.”
Judd O'Connor
Партнёры

Corteva's 50-50 JV with BP is expanding its cover crop/mustard program in Latin America for biofuels, indicating significant growth potential in the region.

Доказательства
“don't know that maybe you've seen the most recent estimate we've had with our JV, 50-50 JV with BP in Latin America, expanding mustard crops in Latin America”
Judd O'Connor
Партнёры

The Bayer licensing agreement is driving stronger-than-expected demand for Corteva's seed technology, positioning the company to become royalty positive ahead of schedule.

Доказательства
“with the Bayer agreement that we signed back in February, we're seeing just very strong demand for our corn and soybean technology.”
Chuck Magro

Конкуренты

Конкуренты

Competitive positioning in the ag industry is shifting, with Corteva's performance standing out, signaling potential share gains versus peers like Syngenta.

Доказательства
“between yourself, you know, Syngenta, BASF. And the numbers, you know, have kind of spoken for themselves thus far.”
Chuck Magro
Внешние сигналы

Альфа цепочки поставок · 4с момента звонка

A1

Management stated the company will become 'royalty positive' later this year, a full year ahead of its original target, driven by its licensing model (100+ licensees) and the Bayer agreement.

Доказательства
“Crossing the milestone of royalty neutrality into royalty positive later this year is a monumental accomplishment... This is the first year that we're going to be royalty positive. That's new information for this morning.”
A2

Energy prices are rising in China and India, causing higher AI production costs and a slowdown in Chinese exports into Brazil. This is a potential inflection point for the global generic crop protection pricing environment.

Доказательства
“With higher energy and oil pricing around the world now, that is adding cost inflation to AI production in the low production jurisdictions around the world, namely India and China. And so we are seeing price increases actually for certain…”
A3

Corteva's biofuels program has achieved a 90%+ farmer retention rate, and the JV with BP in Latin America will start planting material crops in 2027, signaling a fast-moving commercial ramp for its next-gen crop program.

Доказательства
“With that program or retention rate with the farmers that have dove in and taken on this new cropping system has been over 90%... We're going to expand somewhere north of 400,000 acres next year.”
A4

Corteva expects first-half operating EBITDA to grow more than 7% year-over-year due to an early North American season and timing shifts, with the first half now expected to outperform the second half.

Методология и полнота

Анализ основан только на заявлениях менеджмента. Показаны все подтверждённые упоминания компаний: 6. Фактические результаты и прогнозы разделены. Публичные доказательства ограничены восемью короткими атрибутированными цитатами. AI-анализ может быть неполным или ошибочным — проверяйте важные утверждения по первоисточнику.